Etoricoxib and diclofenac are associated with similar cardiovascular risksBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7578.1113-a (Published 23 November 2006) Cite this as: BMJ 2006;333:1113
It's now clear that non-steroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit cyclo-oxygenase-2 (COX 2) are linked to thrombotic cardiovascular events such as heart attack. But experts are still debating whether this risk extends to more traditional NSAIDs. In a pooled analysis …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial